title: A two-step mechanism for TRF2-mediated chromosome-end protection.
abstract: Mammalian telomeres repress DNA-damage activation at natural chromosome ends by recruiting specific inhibitors of the DNA-damage machinery that form a protective complex termed shelterin. Within this complex, TRF2 (also known as TERF2) has a crucial role in end protection through the suppression of ATM activation and the formation of end-to-end chromosome fusions. Here we address the molecular properties of TRF2 that are both necessary and sufficient to protect chromosome ends in mouse embryonic fibroblasts. Our data support a two-step mechanism for TRF2-mediated end protection. First, the dimerization domain of TRF2 is required to inhibit ATM activation, the key initial step involved in the activation of a DNA-damage response (DDR). Next, TRF2 independently suppresses the propagation of DNA-damage signalling downstream of ATM activation. This novel modulation of the DDR at telomeres occurs at the level of the E3 ubiquitin ligase RNF168 (ref. 3). Inhibition of RNF168 at telomeres involves the deubiquitinating enzyme BRCC3 and the ubiquitin ligase UBR5, and is sufficient to suppress chromosome end-to-end fusions. This two-step mechanism for TRF2-mediated end protection helps to explain the apparent paradox of frequent localization of DDR proteins at functional telomeres without concurrent induction of detrimental DNA-repair activities.
authors: Laboratory of Chromosome Biology and Genomic Stability, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.
authors: Keiji
authors: K
authors: Okamoto
authors: Cristina
authors: C
authors: Bartocci
authors: Iliana
authors: I
authors: Ouzounov
authors: Jolene K
authors: JK
authors: Diedrich
authors: John R
authors: JR
authors: Yates
authors: Eros Lazzerini
authors: EL
authors: Denchi
mesh_terms: D000818:Animals; D064007:Ataxia Telangiectasia Mutated Proteins; D018797:Cell Cycle Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D002868:Chromosomal Proteins, Non-Histone / Q000378:metabolism; D033481:Chromosomes, Mammalian / Q000235:genetics / Q000378:metabolism; D004249:DNA Damage; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D000072017:Deubiquitinating Enzymes; D010450:Endopeptidases / Q000172:deficiency / Q000378:metabolism; D004789:Enzyme Activation; D051379:Mice; D055503:Protein Multimerization; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D017434:Protein Structure, Tertiary; D021381:Protein Transport; D015398:Signal Transduction; D016615:Telomere / Q000235:genetics / Q000378:metabolism; D035341:Telomeric Repeat Binding Protein 2 / Q000737:chemistry / Q000378:metabolism*; D025521:Tumor Suppressor Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D000071857:Tumor Suppressor p53-Binding Protein 1; D044767:Ubiquitin-Protein Ligases / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D018797:Cell Cycle Proteins; D002868:Chromosomal Proteins, Non-Histone; D004268:DNA-Binding Proteins; C534796:TRF2 protein, mouse; D035341:Telomeric Repeat Binding Protein 2; C498302:Trp53bp1 protein, mouse; D025521:Tumor Suppressor Proteins; D000071857:Tumor Suppressor p53-Binding Protein 1; C489244:UBR5 protein, mouse; C579124:RNF168 protein, mouse; D044767:Ubiquitin-Protein Ligases; D064007:Ataxia Telangiectasia Mutated Proteins; C576325:Atm protein, mouse; D017346:Protein Serine-Threonine Kinases; D010450:Endopeptidases; C579125:BRCC3 protein, mouse; D000072017:Deubiquitinating Enzymes
references: Curr Biol. 2003 Sep 2;13(17):1549-56
references: 12956959
references: Nature. 2010 Sep 9;467(7312):228-32
references: 20829797
references: Nat Cell Biol. 2005 Jul;7(7):712-8
references: 15968270
references: Mol Cell. 2011 Nov 18;44(4):647-59
references: 22099311
references: Nat Genet. 1997 Oct;17(2):231-5
references: 9326950
references: Science. 2010 Mar 26;327(5973):1657-61
references: 20339076
references: Science. 2008 Feb 22;319(5866):1092-6
references: 18202258
references: Cell. 2012 Aug 17;150(4):697-709
references: 22884692
references: Curr Biol. 2002 Oct 1;12(19):1635-44
references: 12361565
references: EMBO J. 2009 Nov 4;28(21):3390-9
references: 19763083
references: Mol Cell. 2005 Nov 23;20(4):551-61
references: 16307919
references: J Biol Chem. 2008 Mar 21;283(12):7713-20
references: 18171670
references: Cell. 2009 Feb 6;136(3):420-34
references: 19203578
references: Nature. 2010 Aug 19;466(7309):941-6
references: 20725033
references: Nature. 2003 Nov 13;426(6963):194-8
references: 14608368
references: Nature. 2007 Aug 30;448(7157):1068-71
references: 17687332
references: Cytogenet Genome Res. 2005;109(4):491-6
references: 15905643
references: Cell. 2009 Jul 10;138(1):90-103
references: 19596237
references: Nat Genet. 2000 Jul;25(3):347-52
references: 10888888
references: Nat Cell Biol. 2011 Oct 03;13(10):1161-9
references: 21968989
references: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3166-71
references: 19202061
references: Oncogene. 2002 Jan 21;21(4):532-40
references: 11850778
references: Cell. 2009 Feb 6;136(3):435-46
references: 19203579
references: Hum Mol Genet. 2006 Mar 15;15(6):831-8
references: 16446310
references: Genes Dev. 2000 Apr 15;14(8):927-39
references: 10783165
references: Cell. 1998 Feb 6;92(3):401-13
references: 9476899
references: Nature. 2008 Nov 27;456(7221):529-33
references: 18931658
references: Nature. 2008 Nov 27;456(7221):524-8
references: 18931659
references: Cell. 1999 May 14;97(4):503-14
references: 10338214